×
戻る Agenda
S27 : Clinical Trials 2035: Innovations That will Transform the Future of Research
Session Chair(s)
Shigeru Nakaji, MSc
Vice President, RD Opearations, CRDO Office
Astellas Pharma Inc., Japan
Speaker(s)
Janice Chang
TransCelerate Biopharma Inc., United States
Chief Executive Officer
Mamoru Narukawa, PhD, RPh
Kitasato University, Japan
Professor
Takuko Sawada
Shionogi & Co., Ltd., Japan
Director and Vice Chairperson of the Board
Christoph Koenen, MD, MBA
Bayer Ag, Swaziland
Global Head of Clinical Development and Operations
Kazuhiko Mori, PhD, MSc
Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Former Executive Director